# Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI

> **NCT05302817** · PHASE1 · TERMINATED · sponsor: **Xemed LLC** · enrollment: 9 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **COMBINATION_PRODUCT:** Hyperpolarized xenon MRI

## Key facts

- **NCT ID:** NCT05302817
- **Lead sponsor:** Xemed LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-17
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Regulatory compliance.
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05302817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05302817, "Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05302817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*